NCT05171075 2025-12-19
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Active not recruiting
Clinical Trials
6 trialsNCT00942968 2024-04-18
Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
Pfizer
Phase 4 Completed
NCT00952380 2019-04-16
Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients
Pfizer
Phase 2 Completed
NCT02073682 2019-03-06
Cancer Venous Thromboembolism (VTE)
Daiichi Sankyo
Phase 3 Completed
NCT01444612 2017-05-16
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
GlaxoSmithKline
Completed
NCT00480636 2010-08-10
Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients
Pfizer
Completed